Renaissance Technologies's BBNX Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 22,500 shares of Beta Bionics, Inc. (BBNX) worth $447,075, representing 0.00% of the portfolio. First purchased in 2025-Q2, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Renaissance Technologies has initiated a new position in BBNX, representing a fresh investment thesis on this company. Largest addition occurred in Q3 2025, adding 6,000 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Beta Bionics (BBNX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Beta Bionics (BBNX) Trades by Renaissance Technologies
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2025 | +16,500 | New Buy | 16,500 | $14.56 |
| Q3 2025 | +6,000 | Add 36.36% | 22,500 | $19.87 |
Renaissance Technologies's Beta Bionics Investment FAQs
Renaissance Technologies first purchased Beta Bionics, Inc. (BBNX) in Q2 2025, acquiring 16,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Beta Bionics, Inc. (BBNX) for 2 quarters since Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's largest addition to Beta Bionics, Inc. (BBNX) was in Q2 2025, adding 16,500 shares worth $240,240. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 22,500 shares of Beta Bionics, Inc. (BBNX), valued at approximately $447,075. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Beta Bionics, Inc. (BBNX) represents approximately 0.00% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's peak holding in Beta Bionics, Inc. (BBNX) was 22,500 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.